GLOME Holdings, Inc.
8938・Growth Market・Real Estate
Healthcare-Related Business
Group core business providing management support services to alliance medical institutions
| Period | Current | Previous | Change |
|---|---|---|---|
| Revenue | ¥1,869 million | ¥1,904 million | ↓ |
| Operating Profit | ¥319 million | ¥285 million | ↑ |
| Number of Alliance Facilities | 50 facilities (as of end-March 2026) | 54 facilities (as of end-March 2025) | ↓ |
| Total Alliance Facility Beds | 4,826 beds (as of end-March 2026) | 5,280 beds (as of end-March 2025) | ↓ |
| Segment Assets | ¥6,548 million | ¥7,307 million | ↓ |
| Impairment Loss | ¥71 million | － | ↓ |
Business Details
Through consolidated subsidiaries, this business provides multi-layered services—management/administrative/operational guidance, HR and labor training, medical equipment sales, IT support, and money lending—to alliance medical institutions (50 facilities/4,826 beds as of end-March 2026), earning outsourcing fees and other compensation. It also operates a medical tourism business (for inbound patients). This is the flagship segment, accounting for approximately 93% of group revenue. Note that the hospice residence business was closed in February 2026 and the property is now being leased to another company.
Recent Overview
Despite a decline in the number of facilities and beds, operating profit increased 12.1% year on year
In the Healthcare-Related Business for FY2026 (ended March 2026), the number of facilities decreased from 54 to 50 (4,826 beds) due to bed reductions from the termination of outsourcing contracts, and revenue was ¥1,869 million (down 1.8% year on year). On the other hand, operating profit improved to ¥319 million (up 12.1% year on year). The hospice residence business was closed in February 2026 and converted to a leasing arrangement. As a new business, the company disclosed its entry into the grid-scale battery storage business on April 30, 2026, and is currently reviewing projects with the aim of acquiring its first facility in September 2026.
Key Products
Growth Drivers
- Development of new alliance medical institutions in FY2027 (ending March 2027) (plan to acquire one new alliance, 100 beds in total)
- Deepening revenue through strengthening peripheral businesses such as facility management support and IT support for existing alliance medical institutions
- Promotion of centralized purchasing of medical equipment and pharmaceuticals by Fukuyama Iryoki and expansion of synergies with alliance partners (expected revenue of ¥1,815 million in FY2027, ending March 2027)
- Strengthening demand capture in the inbound medical tourism business by GLOME International (expected revenue of ¥204 million in FY2027, ending March 2027)
- Diversification of revenue sources through the new grid-scale battery storage business (targeting acquisition of first facility in September 2026, expected revenue of ¥97 million in FY2027, ending March 2027)
Risks
- Risk of continued decline in the number of alliance facilities and beds due to termination of outsourcing contracts, etc. (50 facilities/4,826 beds as of end-March 2026, a decrease from the prior year-end)
- Risk of failing to meet targets for acquiring new alliance partners (plan to acquire one new alliance, 100 beds, in FY2027, ending March 2027)
- Risk related to collection of outsourcing fees and loans due to deteriorating management conditions at alliance medical institutions (allowance for doubtful accounts recorded)
- Impact of regulatory changes such as medical law regulations and revisions to medical service fee schedules on the management of alliance medical institutions
- Risk of delayed monetization or failure to acquire projects in new businesses such as the grid-scale battery storage business
- Uncertainty regarding demand capture in the medical tourism business
Last updated: June 24, 2026